Race, Gender, and Genetic Polymorphism Contribute to Variability in Acetaminophen Pharmacokinetics, Metabolism, and Protein-Adduct Concentrations in Healthy African-American and European-American Volunteers.

MLA

Court, Michael H., et al. “Race, Gender, and Genetic Polymorphism Contribute to Variability in Acetaminophen Pharmacokinetics, Metabolism, and Protein-Adduct Concentrations in Healthy African-American and European-American Volunteers.” The Journal of Pharmacology and Experimental Therapeutics, vol. 362, no. 3, Sept. 2017, pp. 431–40. EBSCOhost, https://doi.org/10.1124/jpet.117.242107.

APA

Court, M. H., Zhu, Z., Masse, G., Duan, S. X., James, L. P., Harmatz, J. S., & Greenblatt, D. J. (2017). Race, Gender, and Genetic Polymorphism Contribute to Variability in Acetaminophen Pharmacokinetics, Metabolism, and Protein-Adduct Concentrations in Healthy African-American and European-American Volunteers. The Journal of Pharmacology and Experimental Therapeutics, 362(3), 431–440. https://doi.org/10.1124/jpet.117.242107

Chicago

Court, Michael H, Zhaohui Zhu, Gina Masse, Su X Duan, Laura P James, Jerold S Harmatz, and David J Greenblatt. 2017. “Race, Gender, and Genetic Polymorphism Contribute to Variability in Acetaminophen Pharmacokinetics, Metabolism, and Protein-Adduct Concentrations in Healthy African-American and European-American Volunteers.” The Journal of Pharmacology and Experimental Therapeutics 362 (3): 431–40. doi:10.1124/jpet.117.242107.